Nov 11, 2024 05:35PM

Aug 12, 2024 09:00AM

Feb 21, 2024 04:05PM

Mar 2, 2023 08:30AM

Dec 7, 2022 07:47AM

Dec 7, 2022 07:30AM

Jul 18, 2022 07:05AM Entera Bio Announces Execution of Key Regulatory Milestones for EB613, the First Oral Anabolic Drug Proposed for the Treatment of Osteoporosis; Miranda Toledano Assumes CEO Position

May 16, 2022 08:00AM

Mar 21, 2022 04:00PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All